Abstract
The scrapie prion protein denoted PrP 27–30 was discovered by enriching fractions for scrapie infectivity (Prusiner et al. 1982, 1983). This protein migrates during sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) as a broad band with an apparent molecular weight of 27–30 kDa (Bolton et al. 1982; Prusiner et al. 1982). It is derived from PrPSc, a 33- to 35-kDa protein, by limited proteolysis (Oesch et al. 1985). A portion of PrP forms long filamentous structures in scrapie-infected brains (DeArmond et al. 1985), and the purified prions apparently aggregate into rod-shaped structures in brain extracts (Meyer et al. 1986; McKinley et al. 1986). These prion aggregates are ultrastructurally and tinctorially indistinguishable from amyloid (Prusiner et al. 1983). Extensive purification of PrP 27–30 was required before convincing evidence linking the rods and prion infectivity could be obtained. Raising antibodies against PrP 27–30 resulted in the demonstration that filaments in tissues and rods in extracts are composed of PrP (DeArmond et al. 1985; Barry et al. 1985). By negative staining, the individual rods measure 10–20 nm in diameter and 100–200 nm in length. In highly purified preparations, rods usually are found in large clusters, but individual rods can be dispersed by brief sonication (Fig. 1).
This work was supported by research grants from the National Institutes of Health (AG02132 and NS14069), the Senator Jacob Javits Center of Excellence in Neuroscience (NS22786), and State of California, Department of Health Services (contract no. 88–94658), as well as gifts from the Sherman Fairchild Foundation and the Fairleigh S. Dickinson, Jr. Foundation, Inc.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alper T, Haig DA, Clarke MC (1978) The scrapie agent: evidence against its dependence for replication on intrinsic nucleic acid. J Gen Virol 41: 503–516
Baringer JR, Prusiner SB (1978) Experimental scrapie in mice: ultrastructural observations. Ann Neurol 4:205–211
Barry RA, McKinley MP, Bendheim PE, Lewis GK, DeArmond SJ, Prusiner SB (1985) Antibodies to the scrapie protein decorate prion rods. J Immunol 135: 603–613
Bazan JF, Fletterick RJ, McKinley MP, Prusiner SB (1987) Predicted secondary structure and membrane topology of the scrapie prion protein. Protein Eng 1: 125–135
Bendheim PE, Barry RA, DeArmond SJ, Stites DP, Prusiner SB (1984) Antibodies to a scrapie prion protein. Nature 310: 418–421
Bignami A, Parry HB (1971) Aggregations of 35-namometer particles associated with neuronal cytopathic changes in natural scrapie. Science 171: 389–399
Bignami A, Parry HB (1972) Electron microscopic studies of the brain of sheep with natural scrapie. I. The fine structure of neuronal vacuolation. Brain 95: 319–326
Bogonez E, Koshland DE (1985) Solubilization of a vectorial transmembrane receptor in functional form: aspartate receptor of Chemotaxis. Proc Natl Acad Sci USA 82: 4891–4895
Bolton DC, McKinley MP, Prusiner SB (1982) Identification of a protein that purifies with the scrapie prion. Science 218: 1309–1311
Cho HJ (1976) Is the scrapie agent a virus? Nature 262: 411–412
Cho HJ, Grieg AS (1975) Isolation of 14-NM virus-like particles from mouse brain infected with scrapie agent. Nature 257: 685–686
Cho HJ, Grieg AS, Crop CR, Kimberlin RH, Chandler RL, Millson GC (1977) Virus-like particles from both control and scrapie-affected mouse brain. Nature 267: 459–460
David-Ferreira JF, David-Ferreira KL, Gibbs CJ, Jr Morris JA (1968) Scrapie in mice: ultrastructural observations in the cerebral cortex. Proc Soc Exp Biol Med 127: 313–320
DeArmond SJ, McKinley MP, Barry RA, Braunfeld MB, McColloch JR, Prusiner SB (1985) Identification of prion amyloid filaments in scrapie-infected brain. Cell 41: 221–235
Diener TO (1987) PrP and the nature of the scrapie agent. Cell 49: 719–721
Diener TO, McKinley MP, Prusiner SB (1982) Viroids and prions. Proc Natl Acad Sci USA 79: 5220–5224
Diringer H, Gelderblom H, Hilmert H, Ozel M, Edelbluth C, Kimberlin RH (1983a) Scrapie infectivity, fibrils and low molecular weight protein. Nature 306: 476–478
Diringer H, Hilmert H, Simon D, Werner E, Ehlers B (1983b) Towards purification of the scrapie agent. Eur J Biochem 134: 555–560
Field EJ, Narang HK (1972) An electron-microscopic study of scrapie in the rat: further observations on “inclusion bodies” and virus-like particles. J Neurol Sci 17: 347–364
Field EJ, Raine CS (1966) Observations on “dense-body” structure in nerve cells with special reference to scrapie. Res Vet Sci 7: 292–295
Field EJ, Raine CS, Joyce G (1967) Scrapie in the rat: an electron-microscope study. II. Glial inclusions. Acta Neuropathol (Berl) 9: 305–315
Gabizon R, McKinley MP Groth DF, Prusiner SB (1988) Immunoaffinity purification and neutralization of scrapie prion infectivity. Proc Natl Acad Sci USA 85: 6617–6621
Gabizon R, McKinley MP, Prusiner SB (1987) Purified prion proteins and scrapie infectivity copartition into liposomes. Proc Natl Acad Sci USA 84: 4017–4021
Gabizon R, Prusiner SB (1990) Prion liposomes. Biochem J 266: 1–14
Glenner GG (1980) Amyloid deposits and amyloidosis. N Engl J Med 302: 1283–1292
Hope J, Morton LJD, Farquhar CF, Multhaup G, Beyreuther K, Kimberlin RH (1986) The major polypeptide of scrapie-associated fibrils (SAF) has the same size, charge distribution and N-terminal protein sequence as predicted for the normal brain protein (PrP). EMBO J 5:2591–2597
Huang K-S, Bayley H, Khorana HG (1980) Delipidation of bacteriorhodopsin and reconstitution with exogenous phospholipid. Proc Natl Acad Sci USA 77: 323–327
Kitamoto T, Tateishi J, Tashima T, Takeshita I, Barry RA, DeArmond SJ, Prusiner SB (1986) Amyloid plaques in Creutzfeldt-Jakob disease stain with prion protein antibodies. Ann Neurol 20: 204–208
Lampert P, Hooks J, Gibbs CJ, Jr Gajdusek DC (1971) Altered plasma membranes in experimental scrapie. Acta Neuropathol (Berl) 19: 81–93
Malone TG, Marsh RF, Hanson RP, Semancik JS (1979) Hamster scrapie agent: properties, partial purification, and a DNA component. In: Prusiner SB, Hadlow WJ (eds) Slow transmissible diseases of the nervous system, vol 2. Academic, New York, pp 479–488
Manuelidis L, Sklaviadis T, Manuelidis EE (1987) Evidence suggesting that PrP is not the infectious agent in Creutzfeldt-Jakob disease. EMBO J 6: 341–347
McKinley MP, Bolton DC, Prusiner SB (1983) A protease-resistant protein is a structural component of the scrapie prion. Cell 35: 57–62
McKinley MP, Braunfeld MB, Bellinger CG, Prusiner SB (1986) Molecular characteristics of prion rods purified from scrapie-infected hamster brains. J Infect Dis 154: 110–120
McKinley MP, Meyer R, Kenaga L, Rahbar F, Serban A, Gabizon R, Prusiner SB (1991) Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis. J Virol 65:1340–1351
Merz PA, Somerville RA, Wisniewski HM, Iqbal K (1981) Abnormal fibrils from scrapie-infected brain. Acta Neuropathol (Berl) 54: 63–74
Merz PA, Somerville RA, Wisniewski HM, Manuelidis L, Manuelidis EE (1983a) Scrapie-associated fibrils in Creutzfeldt-Jakob disease. Nature 306: 474–476
Merz PA, Wisniewski HM, Somerville RA, Masters CL, Iqbal K (1983b) Ultrastructural morphology of amyloid fibrils from neuritic and amyloid plaques. Acta Neuropathol (Berl) 60: 113–124
Merz PA, Kascsak R, Rubenstein R, Carp RI, Wisniewski HM (1984a) Variations in SAF from different scrapie agents. In: Tateishi J (ed) Proceedings of workshop on slow transmissible diseases. Japanese Ministry of Health and Welfare, Tokyo, pp 137–145
Merz PA, Rohwer RG, Kascsak R, Wisniewski HM, Somerville RA, Gibbs CJ Jr, Gajdusek DC (1984b) Infection-specific particle from the unconventional slow virus diseases. Science 225: 437–440
Merz PA, Kascsak RJ, Rubenstein R, Carp RI, Wisniewski HM (1987) Antisera to scrapie-associated fibril protein and prion protein decorate scrapie-associated fibrils. J Virol 61: 42–49
Meyer RK, McKinley MP, Bowman KA, Braunfeld MB, Barry RA, Prusiner SB (1986) Separation and properties of cellular and scrapie prion proteins. Proc Natl Acad Sci USA 83: 2310–2314
Narang HK (1974a) Ruthenium red and lanthanum nitrate a possible tracer and negative stain for scrapie “particles?” Acta Neuropathol (Berl) 29: 37–43
Narang HK (1974b) An electron microscopic study of the scrapie mouse and rat: further observations on virus-like particles with ruthenium red and lanthanum nitrate as a possible trace and negative stain. Neurobiology 4: 349–363
Oesch B, Westaway D, Wälchli M, McKinley MP, Kent SBH, Aebersold R, Barry RA, Tempst P, Teplow DB, Hood LE, Prusiner SB, Weissmann C (1985) A cellular gene encodes scrapie PrP 27–30 protein. Cell 40: 735–746
Pattison IH, Smith K (1963) Histological observations on experimental scrapie in the mouse. Res Vet Sci 4: 269–275
Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie Science 216: 136–144
Prusiner SB, McKinley MP (eds) (1987) Prions-novel infectious pathogens causing scrapie and Creutzfeldt-Jakob disease. Academic, New York
Prusiner SB, Hadlow WJ, Garfin DE, Cochran SP, Baringer JR, Race RE, Eklund CM (1978) Partial purfication and evidence for multiple molecular forms of the scrapie agent. Biochemistry 17:4993–4997
Prusiner SB, Garfin DE, Baringer JR, Cochran SP, Hadlow WJ, Race RE, Eklund CM (1979) On the partial purification and apparent hydrophobicity of the scrapie agent. In: Prusiner SB, Hadlow WJ (eds) Slow transmissible diseases of the nervous system, vol 2. Academic, New York, pp 425–464
Prusiner SB, Groth DF, McKinley MP, Cochran SP, Bowman KA, Kasper KC (1981) Thiocyanate and hydroxyl ions inactivate the scrapie agent. Proc Natl Acad Sci USA 78: 4606–4610
Prusiner SB, Bolton DC, Groth DF, Bowman KA, Cochran SP, McKinley MP (1982) Further purification and characterization of scrapie prions. Biochemistry 21: 6942–6950
Prusiner SB, McKinley MP, Bowman KA, Bolton DC, Bendheim PE, Groth DF, Glenner GG (1983) Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35: 349–358
Prusiner SB, Groth DF, Bolton DC, Kent SB, Hood LE (1984) Purification and structural studies of a major scrapie prion protein. Cell 38: 127–134
Raine CS, Field EJ (1967) Orientated tubules in axoplasm of cerebellar myelinated nerve fibers in the rat. Acta Neuropathol (Berl) 9: 298–304
Roberts GW, Lofthouse R, Allsop D, Landon M, Kidd M, Prusiner SB, Crow TJ (1988) CNS amyloid proteins in neurodegenerative diseases. Neurology 38: 1534–1540
Rohwer RG (1984) Scrapie infectious agent is virus-like in size and susceptibility to inactivation. Nature 308: 658–662
Siakotos AN, Raveed D, Longa G (1979) The discovery of a particle unique to brain and spleen subcellular fractions from scrapie-infected mice. J Gen Virol 43: 417–422
Sklaviadis T, Manuelidis L, Manuelidis EE (1986) Characterization of major peptides in Creutzfeldt-Jakob disease and scrapie. Proc Natl Acad Sci USA 83: 6146–6150
Somerville RA (1985) Ultrastructural links between scrapie and Alzheimer’s disease. Lancet 1:504–506
Somerville RA, Ritchie LA, Gibson PH (1989) Structural and biochemical evidence that scrapie-associated fibrils assemble in vivo. J Gen Virol 70: 25–35
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
McKinley, M.P., Prusiner, S.B. (1991). Ultrastructural Studies of Prions. In: Chesebro, B.W. (eds) Transmissible Spongiform Encephalopathies:. Current Topics in Microbiology and Immunology, vol 172. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76540-7_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-76540-7_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-76542-1
Online ISBN: 978-3-642-76540-7
eBook Packages: Springer Book Archive